ISO 13485:2003, specifies requirements for a quality management system that consistently provides medical devices and related services that meet customer and regulatory requirements specific to this industry.
“I am very proud that we have been awarded these certifications to demonstrate our commitment to the continuous improvement of our processes and to customer satisfaction,” stated Martin Kunz, CEO of Eurofins MWG Operon, Inc. “These certificates are also an important step in the expansion of Eurofins MWG Operon products and services beyond research use only applications and into the diagnostics market.”
The certificates can be viewed and downloaded at www.operon.com/company/certificates.aspx
About Eurofins MWG Operon
Eurofins MWG Operon, a member of the Eurofins Group with major offices and production facilities in the United States, Europe, and Asia, is an international provider of DNA sequencing services, DNA synthesis products, and bioinformatic services for academic and industrial research. The company’s strengths are its strong customer orientation, fast service, and high quality. For further information, please visit our website at: www.operon.com.
Contact Information:
Paul Brown
Head of Marketing
